Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
|Videos|June 25, 2018
The Future of Specialty Pharmacy Accreditation
Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses developments for ACHC in the pharmacy accreditation space.
Advertisement
Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses developments for ACHC in the pharmacy accreditation space.
Advertisement
Related to this article
FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
The once-daily tablet is the third approved treatment for fibrodysplasia ossificans progressiva (FOP), with CYP3A4 and metformin interaction guidance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
3
Why Patients Fear Statins Will Affect Their Memory
4
Precision in Practice: Biomarker Testing and Treatment Selection in Primary Advanced or Recurrent Endometrial Cancer
5